{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:48:29Z","timestamp":1789058909963,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.semarthrit.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T02:18:40Z","timestamp":1434593920000},"page":"284-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles"],"prefix":"10.1016","volume":"45","author":[{"given":"Kathryn S.","family":"Torok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Kurzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Yabes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Magee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbe N.","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Thomas","family":"Medsger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Feghali-Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.06.006_bib1","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumato"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/BOR.0b013e328309a5eb","article-title":"New developments in localized scleroderma","volume":"20","author":"Zulian","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib3","first-page":"171","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano","year":"2003","journal-title":"Eur J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.semarthrit.2015.06.006_bib4","first-page":"S787","article-title":"Description of the Localized Scleroderma Subgroup of CARRAnet Registry","volume":"63","author":"WU","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaad.2005.10.020","article-title":"Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients","volume":"54","author":"Sommer","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-104-6-849","article-title":"Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities","volume":"104","author":"Falanga","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib8","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/j.1468-3083.2012.04581.x","article-title":"Clinicopathological study of 81 cases of localized and systemic scleroderma","volume":"27","author":"Succaria","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000372-199806000-00003","article-title":"Histopathologic differentiation between localized and systemic scleroderma","volume":"20","author":"Torres","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.semarthrit.2012.03.014","article-title":"Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines","volume":"42","author":"Hasegawa","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib14","first-page":"443","article-title":"Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies","volume":"48","author":"Keystone","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib15","first-page":"264","article-title":"Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma)","volume":"97","author":"Inoshita","year":"1981","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib16","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib17","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1023\/A:1011024313525","article-title":"Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation","volume":"21","author":"Valentini","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01262331","article-title":"Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma","volume":"287","author":"Ihn","year":"1995","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000071783","article-title":"Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma","volume":"207","author":"Hasegawa","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.patbio.2009.11.003","article-title":"Cytokines in systemic sclerosis","volume":"60","author":"Baraut","year":"2012","journal-title":"Pathol Biol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","article-title":"Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis","volume":"42","author":"Atamas","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib24","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","article-title":"Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis","volume":"56","author":"Parel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib25","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.24432","article-title":"Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis","volume":"60","author":"Fuschiotti","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib28","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cyto.2011.04.001","article-title":"Cytokine profiles in localized scleroderma and relationship to clinical features","volume":"55","author":"Kurzinski","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib30","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1186\/ar4378","article-title":"Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma","volume":"15","author":"Magee","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archderm.1994.01690100117021","article-title":"Demonstration of interleukin 8 in serum samples of patients with localized scleroderma","volume":"130","author":"Ihn","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.5114\/aoms.2012.32421","article-title":"Interleukin-17 A and interleukin-23 in morphea","volume":"8","author":"Danczak-Pazdrowska","year":"2012","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5114\/ceji.2012.30800","article-title":"Interleukin 1 beta in morphea","volume":"37","author":"Danczak-Pazdrowska","year":"2012","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib35","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures","volume":"36","author":"Arkachaisri","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","article-title":"The localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical population","volume":"69","author":"Kelsey","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib38","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","article-title":"The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib39","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaad.2013.11.037","article-title":"Correlates of self-reported quality of life in adults and children with morphea","volume":"70","author":"Das","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib40","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3899\/jrheum.080098","article-title":"Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disorder","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3899\/jrheum.110210","article-title":"Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study","volume":"39","author":"Torok","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib43","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib44","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib45","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib46","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.37742","article-title":"Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis","volume":"65","author":"Liu","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib48","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17 A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mai.2001.114707","article-title":"Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines","volume":"107","author":"Giustizieri","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don\u2019t know","volume":"16","author":"Shi","year":"2006","journal-title":"Cell Res"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archdermatol.2010.120","article-title":"Treatment of recalcitrant generalized morphea with infliximab","volume":"146","author":"Diab","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib52","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.1996.03890310088013","article-title":"Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis","volume":"132","author":"Salmon-Ehr","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2015.06.006_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:20:55Z","timestamp":1748456455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017215001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0049017215001444"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.006","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}